Vical (VICL -0.3%) says it's inked a worldwide, nonexclusive license of its patented Vaxfectin...

|About: Vical Incorporated (VICL)|By:, SA News Editor

Vical (VICL -0.3%) says it's inked a worldwide, nonexclusive license of its patented Vaxfectin adjuvant to Cyvax, a privately held vaccine development company, for use in malaria vaccines. Financial terms of the agreement were not disclosed.